Enterprise record

NovoCure Ltd

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:08e6545e-668c-4329-88ad-972bf06af997Version: public-1As of: unavailable

20 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 28, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 28, 2026

    Supports 3 claims
    • Legal Name: NovoCure Ltd · Claim reviewed: Sep 28, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 28, 2026
    • Published Fact: US · Claim reviewed: Sep 28, 2026

  2. DEF 14A nvcr-20260420.htm

    sec proxy · Source published: Apr 20, 2026 · Retrieved: Sep 2, 2026

    Supports 11 claims
    • Leadership Role: Allyson Ocean: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Asaf Danziger: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: David Hung: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Jeryl Hilleman: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Kinyip Gabriel Leung: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Kristin Stafford: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Martin Madden: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Member A Non-Employee: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Timothy Scannell: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: William Doyle: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: William Vernon: Director · Claim reviewed: Sep 28, 2026

  3. NVCR 10-K executive officers

    sec filing · Source published: Feb 26, 2026 · Retrieved: May 5, 2026

    Supports 6 claims
    • Leadership Role: Barak Ben-Arye: General Counsel · Claim reviewed: Sep 28, 2026
    • Leadership Role: Christoph Brackmann: Chief Financial Officer · Claim reviewed: Sep 28, 2026
    • Leadership Role: Frank Leonard: Chief Executive Officer · Claim reviewed: Sep 28, 2026
    • Leadership Role: Michael Puri: Chief Human Resources Officer · Claim reviewed: Sep 28, 2026
    • Leadership Role: Mukund Paravasthu: Chief Operating Officer · Claim reviewed: Sep 28, 2026
    • Leadership Role: Uri Weinberg: Chief Medical Officer and Chief Innovation Officer · Claim reviewed: Sep 28, 2026